Surveillance of Fungal Infections During Construction Activity

This study is currently recruiting participants.

Verified by University Hospital Inselspital, Berne, June 2008

First Received: May 14, 2007 Last Updated: June 4, 2008 History of Changes

Sponsor:	University Hospital Inselspital, Berne
Information provided by:	University Hospital Inselspital, Berne
ClinicalTrials.gov Identifier:	NCT00473252

Purpose

Fungal infections in immunocompromised patients occuring during construction activities in hospitals have repeatedly been reported.

However, the question of a causal relation between construction activities and infections has never been addressed systematically and prospectively.

To answer this question, we will monitor our immunosuppressed patients' health status, as well as fine dust and aspergillus spore contents in the air during a three year construction activity period in our hospital.

Condition
Aspergillosis

Study Type:	Observational
Study Design:	Prospective

Resource links provided by NLM:

MedlinePlus related topics: Fungal Infections Molds

U.S. FDA Resources

Further study details as provided by University Hospital Inselspital, Berne:

Estimated Enrollment:	200
Study Start Date:	May 2006
Estimated Study Completion Date:	May 2009

Eligibility

Ages Eligible for Study:	16 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Kidney transplantation
Chronic hemodialysis treatment

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00473252

Contacts

Contact: Andreas Pasch, MD

0041 31 632 2198

andreas.pasch@insel.ch

Locations

Switzerland
Dept. Nephrology & Hypertension, Univ. Hospital Bern	Recruiting
Bern, Switzerland, 3010
Contact: Andreas Pasch, MD 0041 31 632 2198 andreas.pasch@insel.ch

Sponsors and Collaborators

University Hospital Inselspital, Berne

Investigators

Study Director:

Andreas Pasch, MD

University of Bern

More Information

No publications provided

Study ID Numbers:	BE003
Study First Received:	May 14, 2007
Last Updated:	June 4, 2008
ClinicalTrials.gov Identifier:	NCT00473252 History of Changes
Health Authority:	Switzerland: Ethikkommission

Keywords provided by University Hospital Inselspital, Berne:

aspergillus infections
immunosuppression
kidney transplantation
hemodialysis

galactomannan test
fine dust
construction activity
airborne aspergillus spores

Additional relevant MeSH terms:

Mycoses
Aspergillosis

ClinicalTrials.gov processed this record on November 27, 2009